publication . Article . 2021

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections

Srinivasa Reddy Bonam; Niranjan G. Kotla; Raghvendra A. Bohara; Yury Rochev; Thomas J. Webster; Jagadeesh Bayry;
Open Access English
  • Published: 01 Feb 2021
  • Publisher: HAL CCSD
  • Country: France
Abstract
COVID-19, coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. At the time of writing this (October 14, 2020), more than 38.4 million people have become affected, and 1.0 million people have died across the world. The death rate is undoubtedly correlated with the cytokine storm and other pathological pulmonary characteristics, as a result of which the lungs cannot provide sufficient oxygen to the body's vital organs. While diversified drugs have been tested as a first line therapy, the complexity of fatal cases has not been reduced so far, and the world is looking for a treatment to combat th...
Persistent Identifiers
Subjects
free text keywords: Coronavirus COVID-19 Influenza, Pulmonary drug delivery SARS, SARS-CoV-2 MERS, Nanomedicine Nanotherapeutics Pathophysiology Nanotechnology, [SDV.IMM]Life Sciences [q-bio]/Immunology, [SDV]Life Sciences [q-bio], Biotechnology, General Materials Science, Bioengineering, Pharmaceutical Science, Biomedical Engineering, Review, Coronavirus, COVID-19, Influenza, Pulmonary drug delivery, SARS, SARS-CoV-2, MERS, Nanomedicine, Nanotherapeutics, Pathophysiology, Nanotechnology, Middle East respiratory syndrome, medicine.disease, medicine, Coronavirus, medicine.disease_cause, Pandemic, Intensive care medicine, medicine.medical_specialty, ARDS, Review article, Pulmonary pathology, Mortality rate, Cytokine storm, business.industry, business
Related Organizations
Funded by
SFI| C�RAM - Centre for Research in Medical Devices
Project
  • Funder: Science Foundation Ireland (SFI)
  • Project Code: 13/RC/2073
  • Funding stream: SFI Research Centres
,
EC| INDIGO
Project
INDIGO
Effective and Affordable Flu Vaccines for the World
  • Funder: European Commission (EC)
  • Project Code: 874653
  • Funding stream: H2020 | RIA
Communities
COVID-19
Any information missing or wrong?Report an Issue